Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Top Cited Papers
- 1 July 2010
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 9 (7), 727-739
- https://doi.org/10.1016/s1474-4422(10)70094-6
Abstract
No abstract availableKeywords
Funding Information
- Rea Charitable Trust
- Medical Research Council
- National Multiple Sclerosis Society
- Aims2Cure
This publication has 99 references indexed in Scilit:
- Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scoreThe Lancet Neurology, 2009
- Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosisAnnals of Neurology, 2009
- Smoking and Disease Progression in Multiple SclerosisArchives of Neurology, 2009
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociNature Genetics, 2009
- Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological eventProceedings of the National Academy of Sciences of the United States of America, 2008
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- Vitamin D DeficiencyThe New England Journal of Medicine, 2007
- Serum 25-Hydroxyvitamin D Levels and Risk of Multiple SclerosisJAMA, 2006
- The endophenotype concept in psychiatric geneticsPsychological Medicine, 2006
- Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006